A-SYNAPTIC CORP.

TORONTO, A6 · Founded 2018 · CIK 0001913553 · Medtech · Private

Transdermal delivery technology for targeted cannabinoid drug administration

asynaptic.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.7M
3 Form D · Dec 2025
10 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$875,000
Private capital raisedForm D · SEC$300,000
Private capital raisedForm D · SEC$533,100
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1230DIH HOLDING US, INC.—$3.3M
1231Cell Detect, Inc.—$2.0M
1232RADOM CORPORATION—$6.2M
1233A-SYNAPTIC CORP.—$1.7M
1234Anumana, Inc.—$32M
1235ETHOS RESEARCH AND DEVELOPMENT, LLC——
1236Scanadu Inc—$45M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Jack AltshulerDirector · Executive Officer
  • William BeckmanExecutive Officer
  • Brian BurkeDirector
  • Henry Crowley, Jr.Executive Officer
  • James MongiardoDirector · Executive Officer
  • David ParkerDirector
  • Cameron PrangeExecutive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.